.jpg?width=1754&height=637&name=SP_Logo_Color_RGB%202020update%20(1).jpg "Orsini Specialty Pharmacy Logo"){kind=logo}
ALZHEIMER'S DISEASE TREATMENT
About the Disease
Alzheimer’s disease is an irreversible, degenerative brain disorder that slowly destroys memory, thinking and behavior. Over time, symptoms progress and eventually interfere with the ability to perform daily tasks. In the US, more than 6 million people of all ages are currently living with Alzheimer’s disease, and it is estimated that by 2050 the number of people age 65 and older could grow to 12.7 million.
About our Patient Care
We work with the physician's office and insurance on a patient's behalf so that Alzheimer’s patients have more time to focus on their treatment and quality of life. We are here to listen, provide counseling on treatment, including side-effect management, and assist with sourcing third-party financial assistance.
As part of treatment, we provide:
Dedicated Care Team
We provide prescribers and patients with a dedicated patient care team for Alzheimer’s disease. This includes a primary pharmacy contact, clinical education, side-effects management, scheduled refill calls, and a direct phone, fax and email address.
Shipping and Coordination of Care
We provide free overnight delivery of medications and necessary medical supplies and manage the coordination of care between prescribers, sites of care, nurses and patients to ensure dispenses and drug delivery align with the date and location of service.
Financial Assistance Coordination
We successfully identify and assist enrolling patients into any and all manufacturer co-pay and foundation support programs in order to minimize a potential financial burden to patients given the high-cost of specialty medications.
24/7 Access to a Pharmacist
We provide prescribers and patients access to a pharmacist 24/7 to ensure patients are always cared for.
Supported Treatments
Click on the specialty drug name below to expand and see more information.
ADUHELM™ (aducanumab-avwa)
Brand Name | ADUHELM™ (aducanumab-avwa)
Manufacturer | Biogen®
Route of Administration | Injection, for intravenous use
Approved Indication | ADUHELM is indicated for the treatment of Alzheimer’s disease
Self-Administration | No
Product Website | https://www.aduhelm.com/
Partnering with Prescribers
Licensed prescribers can submit a completed enrollment form directly to our Admission team. We will begin the process and communicate with your office every step of the way.
